|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM
and Zhang GZ: Biological functions of microRNAs: A review. J
Physiol Biochem. 67:129–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iorio MV and Croce CM: microRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song S and Ajani JA: The role of microRNAs
in cancers of the upper gastrointestinal tract. Nat Rev
Gastroenterol Hepatol. 10:109–118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohshima K, Inoue K, Fujiwara A, Hatakeyama
K, Kanto K, Watanabe Y, Muramatsu K, Fukuda Y, Ogura S, Yamaguchi
K, et al: Let-7 microRNA family is selectively secreted into the
extracellular environment via exosomes in a metastatic gastric
cancer cell line. PLoS One. 5:e132472010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng S, Kuang Z, Sheng C, Zhang Y, Xu H
and Cheng Q: Association of microRNA-196a-2 gene polymorphism with
gastric cancer risk in a Chinese population. Dig Dis Sci.
55:2288–2293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT,
Xia YJ, Ye ZY and Tao HQ: MicroRNA-101 is down-regulated in gastric
cancer and involved in cell migration and invasion. Eur J Cancer.
46:2295–2303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lai KW, Koh KX, Loh M, Tada K, Subramaniam
MM, Lim XY, Vaithilingam A, Salto-Tellez M, Iacopetta B, Ito Y, et
al: Singapore Gastric Cancer Consortium: MicroRNA-130b regulates
the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer.
46:1456–1463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun C, Li S, Yang C, Xi Y, Wang L, Zhang F
and Li D: MicroRNA-187-3p mitigates non-small cell lung cancer
(NSCLC) development through down-regulation of BCL6. Biochem
Biophys Res Commun. 471:82–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang F, Luo Y, Shao Z, Xu L, Liu X, Niu
Y, Shi J, Sun X, Liu Y, Ding Y, et al: MicroRNA-187, a downstream
effector of TGFβ pathway, suppresses Smad-mediated
epithelial-mesenchymal transition in colorectal cancer. Cancer
Lett. 373:203–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Casanova-Salas I, Masiá E, Armiñán A,
Calatrava A, Mancarella C, Rubio-Briones J, Scotlandi K, Vicent MJ
and López-Guerrero JA: MiR-187 targets the androgen-regulated gene
ALDH1A3 in prostate cancer. PLoS One. 10:e01255762015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mulrane L, Madden SF, Brennan DJ, Gremel
G, McGee SF, McNally S, Martin F, Crown JP, Jirström K, Higgins DG,
et al: miR-187 is an independent prognostic factor in breast cancer
and confers increased invasive potential in vitro. Clin Cancer Res.
18:6702–6713. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davis-Dusenbery BN and Hata A: MicroRNA in
cancer: The Involvement of aberrant MicroRNA biogenesis regulatory
pathways. Genes Cancer. 1:1100–1114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu R, Zhang C, Hu Z, Li G, Wang C, Yang
C, Huang D, Chen X, Zhang H, Zhuang R, et al: A five-microRNA
signature identified from genome-wide serum microRNA expression
profiling serves as a fingerprint for gastric cancer diagnosis. Eur
J Cancer. 47:784–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Slack FJ and Weidhaas JB: MicroRNA in
cancer prognosis. N Engl J Med. 359:2720–2722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Casanova-Salas I, Rubio-Briones J,
Calatrava A, Mancarella C, Masiá E, Casanova J, Fernández-Serra A,
Rubio L, Ramírez-Backhaus M, Armiñán A, et al: Identification of
miR-187 and miR-182 as biomarkers of early diagnosis and prognosis
in patients with prostate cancer treated with radical
prostatectomy. J Urol. 192:252–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katoh M and Katoh M: Integrative genomic
analyses of CXCR4: Transcriptional regulation of CXCR4 based on
TGFbeta, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1,
SOX17, and GFI1 transcription factors. Int J Oncol. 36:415–420.
2010.PubMed/NCBI
|
|
21
|
Zhu C-P, Wang J, Shi B, Hu PF, Ning BF,
Zhang Q, Chen F, Chen WS, Zhang X and Xie WF: The transcription
factor FOXA2 suppresses gastric tumorigenesis in vitro and in vivo.
Dig Dis Sci. 60:109–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
